Events

Sanofi is excited to announce that they are now accepting applications for their 2026 Golden Ticket in partnership with LabCentral. The recipient of this award will receive a $50,000 credit towards lab space at LabCentral’s 700 Main Street facility and the opportunity to closely partner with Sanofi.

Sanofi is seeking biotechs developing advanced human-relevant disease modeling platforms that bridge the preclinical-to-clinical gap. 

Technologies of interest include: 

• Organoids and organ-on-chip systems
• AI/ML-enhanced predictive models
• High-throughput screening platforms
• Computational biology tools
• Biomaterial-based systems

Applications should demonstrate potential to improve target validation, predict therapeutic responses, enhance safety assessment, or enable precision medicine approaches across immunology, oncology, neurology, or ophthalmology. 

APPLY NOW!